Evidence map›Paper›PMID 36982680›Full record

ArticleInternational journal of molecular sciences2023

Influence of HA on Release Process of Anionic and Cationic API Incorporated into Hydrophilic Gel.

Dorota Wójcik-Pastuszka, Karolina Stawicka, Andrzej Dryś, Witold Musiał

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Dorota Wójcik-PastuszkaDepartment of Physical Chemistry and Biophysics, Faculty of Pharmacy, Wrocław Medical University, ul. Borowska 211A, 55-556 Wrocław, Poland.ORCID 0000-0002-4834-1125
Karolina StawickaDepartment of Physical Chemistry and Biophysics, Faculty of Pharmacy, Wrocław Medical University, ul. Borowska 211A, 55-556 Wrocław, Poland.
Andrzej DryśDepartment of Physical Chemistry and Biophysics, Faculty of Pharmacy, Wrocław Medical University, ul. Borowska 211A, 55-556 Wrocław, Poland.
Witold MusiałDepartment of Physical Chemistry and Biophysics, Faculty of Pharmacy, Wrocław Medical University, ul. Borowska 211A, 55-556 Wrocław, Poland.
Wroclaw Medical University · PL

Funding

Wroclaw Medical University SUBZD.D060.22.034.
6 · The paper itself

Abstract

The properties of sodium hyaluronate (HA), such as hygroscopicity, flexibility, the ability to form hydrogels, as well as biocompatibility and biodegradability, are beneficial for the applications in pharmaceutical technology, cosmetics industry, and aesthetic medicine. The aim of this study was to prepare HA-based hydrogels doped with active pharmaceutical ingredient (API): a cationic drug-lidocaine hydrochloride or anionic drug-sodium. The interaction between the carrier and the implemented active pharmaceutical substances was evaluated in prepared systems by applying viscometric measurements, performing release tests of the drug from the obtained formulations, and carrying out FTIR and DSC. The data from release studies were analyzed using the zero-, first-, and second-order kinetics and Higuchi, Korsmeyer-Peppas, and Hixon-Crowell models. The respective kinetic parameters: the release rate constants, the half-release time and, in the case of the Korsmeyer-Peppas equation, the n parameter were calculated. The variability between the obtained release profiles was studied by calculating the difference (f

Indexed as

HydrogelsTechnology, PharmaceuticalCationsDelayed-Action PreparationsDrug CompoundingKineticsSolubilityCationsDelayed-Action PreparationsHydrogelsDSC studyFTIR studyhydrogelskineticslidocaine hydrochloridereleasesodium hyaluronatesodium naproxen

Identifiers

PMID36982680
PMCPMC10059958
OpenAlexW4324382614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.